Depomed Says Teva Unit Infringed Diabetes Patents
Pharmaceutical company Depomed Inc. has asked a California court for summary judgment in a case accusing a Teva Pharmaceutical Industries Ltd. subsidiary of infringing two patents related to the diabetes drug...To view the full article, register now.
Already a subscriber? Click here to view full article